Edith M. Lord

Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy.

R. Barth, J. Frelinger, R. Looney, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells.

N. Shastri, D. Penney, J. Frelinger, 1996, Proceedings of the National Academy of Sciences of the United States of America.

T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes.

J. Frelinger, E. Lord, R. A. Willis, 2001, Journal of immunological methods.

Alteration of the metastatic potential of line 1 lung carcinoma cells: opposite effects of class I antigen induction by interferons versus DMSO or gene transfection.

J. Frelinger, T. Blieden, Edith M. Lord, 1990, Cellular immunology.

Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts

E M Lord, J. Frelinger, B. Fenton, 2003, British Journal of Cancer.

Tumours can act as adjuvants for humoral immunity

D. Brown, J. Frelinger, E. Lord, 2001, Immunology.

Interleukin‐3 and granulocyte–macrophage colony‐stimulating factor enhance the generation and function of dendritic cells

J. Frelinger, Woodward, Lord, 1999, Immunology.